Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""therapeutic"" wg kryterium: Temat


Tytuł:
Oral midodrine for prophylaxis against post-spinal anesthesia hypotension during hip arthroplasty in elderly population: a randomized controlled trial.
Autorzy:
Amin S; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Hasanin A; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. .
Mansour R; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Mostafa M; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Zakaria D; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Arafa AS; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Yassin A; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ziada H; Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2024 Feb 14; Vol. 24 (1), pp. 64. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Midodrine*/therapeutic use
Anesthesia, Spinal*/adverse effects
Anesthesia, Spinal*/methods
Arthroplasty, Replacement, Hip*/adverse effects
Hypotension*/epidemiology
Hypertension*/complications
Humans ; Aged ; Ephedrine/therapeutic use ; Bradycardia/epidemiology ; Bradycardia/prevention & control ; Bradycardia/complications ; Vasoconstrictor Agents ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Improving cardiovascular control in a hypertensive population in primary care. Results from a staff training intervention.
Autorzy:
Quester R; Närhälsan Bollebygd Health Care Centre, Bollebygd, Sweden.; Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Björck S; Centre of Registers Västra Götaland, Gothenburg, Sweden.
Manhem K; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.; Department of Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Nåtman J; Centre of Registers Västra Götaland, Gothenburg, Sweden.
Andersson S; Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.
Hjerpe P; Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.
Pokaż więcej
Źródło:
Scandinavian journal of primary health care [Scand J Prim Health Care] 2024 Jun; Vol. 42 (2), pp. 347-354. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/epidemiology
Humans ; Cholesterol, LDL/pharmacology ; Cholesterol, LDL/therapeutic use ; Pilot Projects ; Blood Pressure/physiology ; Cholesterol ; Primary Health Care
Czasopismo naukowe
Tytuł:
The Impact of Timing of Fixed Dose Triple Antihypertensive Combinations on Ambulatory Blood Pressure Monitoring Parameters.
Autorzy:
Ileri C; Tavsanli Doc. Dr Mustafa Kalemli State Hospital, Cardiology Clinic, Kutahya, Turkey.
Dogan Z; Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey.
Ozben B; Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey.
Bircan L; Tavsanlı Doc. Dr Mustafa Kalemli State Hospital, Internal Medicine Clinic, Kutahya, Turkey.
Acet A; Tavsanlı Doc. Dr Mustafa Kalemli State Hospital, Internal Medicine Clinic, Kutahya, Turkey.
Sen T; Kutahya Evliya Celebi Education and Research Hospital, Department of Cardiology, Dumlupinar University School of Medicine, Kutahya, Turkey.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2224941.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Male ; Humans ; Blood Pressure Monitoring, Ambulatory ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Blood Pressure
Czasopismo naukowe
Tytuł:
Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries.
Autorzy:
Gadanec LK; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Swiderski J; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Apostolopoulos V; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.; Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC 3021, Australia.
Kelaidonis K; NewDrug PC, Patras Science Park, 26 504 Patras, Greece.
Vidali VP; Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research 'Demokritos', Ag. Paraskevi, 153 41 Athens, Greece.
Canko A; Institute of Nanoscience and Nanotechnology, National Centre for Scientific Research 'Demokritos', Ag. Paraskevi, 153 41 Athens, Greece.
Moore GJ; Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada.; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Matsoukas JM; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.; NewDrug PC, Patras Science Park, 26 504 Patras, Greece.; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Department of Chemistry, University of Patras, 265 04 Patras, Greece.
Zulli A; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 16; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin II Type 1 Receptor Blockers*/therapeutic use
Hypertension*/drug therapy
Rabbits ; Male ; Animals ; Telmisartan/pharmacology ; Angiotensin-Converting Enzyme 2/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Iliac Artery ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Benzimidazoles/therapeutic use ; Tetrazoles/pharmacology ; Tetrazoles/therapeutic use ; Blood Pressure
Czasopismo naukowe
Tytuł:
Predictors of HbA 1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study.
Autorzy:
Tan WY; Saw Swee Hock School of Public Health, National University of Singapore, MD1 - Tahir Foundation Building, 12 Science Drive 2, #11, Singapore, 117549, Singapore. .
Hsu W; Institute of Data Science, National University of Singapore, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore.
Lee ML; Institute of Data Science, National University of Singapore, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore.
Tan NC; SingHealth Polyclinics, SingHealth, Singapore, Singapore.; Family Medicine Academic Clinical Programme, SingHealth-Duke NUS Academic Medical Centre, Singapore, Singapore.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 28; Vol. 13 (1), pp. 20891. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Diabetes Mellitus, Type 2*/complications
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Hypertension*/complications
Adult ; Humans ; Hypoglycemic Agents/pharmacology ; Cohort Studies ; Retrospective Studies ; Creatinine/therapeutic use ; Drug Therapy, Combination ; Sulfonylurea Compounds/adverse effects ; Angiotensins ; Cholesterol/therapeutic use
Czasopismo naukowe
Tytuł:
Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy.
Autorzy:
Zhang Z; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Fu X; Department of Integrated Traditional Chinese and Western Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zhou F; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Zhang D; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Xu Y; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Fan Z; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Wen S; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Shao Y; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Yao Z; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
He Y; Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Pokaż więcej
Źródło:
Journal of diabetes research [J Diabetes Res] 2024 Jan 20; Vol. 2024, pp. 6942156. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Experimental*/complications
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
MicroRNAs*/genetics
MicroRNAs*/therapeutic use
Hypertension*/drug therapy
Drugs, Chinese Herbal*
Mice ; Humans ; Animals ; Disease Models, Animal ; Mesangial Cells/metabolism ; Fibrosis ; RNA-Binding Proteins ; Calcium-Binding Proteins ; alpha-Mannosidase/metabolism ; alpha-Mannosidase/therapeutic use
Czasopismo naukowe
Tytuł:
Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
Autorzy:
Trentin-Sonoda M; Kidney Research Centre, Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Cheff V; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Gutsol A; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Hébert RL; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 06; Vol. 18 (12), pp. e0295284. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Hypertension*/complications
Hypertension*/drug therapy
Humans ; Male ; Female ; Animals ; Mice ; Canagliflozin/pharmacology ; Canagliflozin/therapeutic use ; Creatinine ; Kidney
Czasopismo naukowe
Tytuł:
Antihypertensive medication persistence and adherence among non-Hispanic Asian US patients with hypertension and fee-for-service Medicare health insurance.
Autorzy:
Choi E; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Mizuno H; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.; Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Wang Z; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Fang C; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Mefford MT; Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, California, United States of America.
Reynolds K; Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, California, United States of America.; Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California, United States of America.
Ghazi L; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Shimbo D; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Muntner P; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300372. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*
Adult ; Humans ; Aged ; United States ; Medicare ; Medication Adherence ; Ethnicity
Czasopismo naukowe
Tytuł:
The prevalence and determinants of blood pressure control among hypertension patients in eastern Zimbabwe: A cross-sectional study.
Autorzy:
Mundagowa PT; Africa University Clinical Research Center, Africa University, Mutare, Zimbabwe.; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States of America.
Zambezi P; Africa University Clinical Research Center, Africa University, Mutare, Zimbabwe.
Muchemwa-Munasirei P; College of Social Sciences, Theology, Humanities and Education, Africa University, Mutare, Zimbabwe.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0293812. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; Middle Aged ; Aged ; Blood Pressure ; Cross-Sectional Studies ; Prevalence ; Zimbabwe/epidemiology
Czasopismo naukowe
Tytuł:
Prescription drug coverage and effective coverage of three chronic conditions of high prevalence in Chile: Hypertension, diabetes and dyslipidemia.
Autorzy:
Matute I; Centro de Epidemiología y Políticas de Salud, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Castillo-Laborde C; Centro de Epidemiología y Políticas de Salud, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 12; Vol. 19 (2), pp. e0297807. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*/drug therapy
Diabetes Mellitus*/economics
Diabetes Mellitus*/epidemiology
Dyslipidemias*/drug therapy
Dyslipidemias*/economics
Dyslipidemias*/epidemiology
Hypertension*/drug therapy
Hypertension*/economics
Hypertension*/epidemiology
Prescription Drugs*/economics
Prescription Drugs*/therapeutic use
Insurance Coverage*/economics
Insurance Coverage*/statistics & numerical data
Insurance, Health*/economics
Humans ; Chile/epidemiology ; Chronic Disease ; Cross-Sectional Studies ; Prevalence ; South American People
Czasopismo naukowe
Tytuł:
New Insights into the Nephroprotective Potential of Lercanidipine.
Autorzy:
Hajdys J; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Fularski P; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Leszto K; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Majchrowicz G; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Stabrawa M; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Młynarska E; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Rysz J; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Franczyk B; Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Żeromskiego 113, 90-549 Lodz, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 13; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hypertension*
Dihydropyridines*/pharmacology
Dihydropyridines*/therapeutic use
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Humans ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure
Czasopismo naukowe
Tytuł:
Alpha-Linolenic Acid and Cardiovascular Events: A Narrative Review.
Autorzy:
Bertoni C; Department of Veterinary Sciences for Health, Animal Production and Food Safety, University of Milan, 20122 Milan, Italy.
Abodi M; Department of Veterinary Sciences for Health, Animal Production and Food Safety, University of Milan, 20122 Milan, Italy.
D'Oria V; Pediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Milani GP; Pediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Agostoni C; Pediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Mazzocchi A; Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 20; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Fatty Acids, Omega-3*/pharmacology
Fatty Acids, Omega-3*/therapeutic use
Hypertension*
Cardiovascular Diseases*/drug therapy
Cardiovascular Diseases*/prevention & control
Adult ; Child ; Humans ; alpha-Linolenic Acid/pharmacology ; alpha-Linolenic Acid/therapeutic use ; Antihypertensive Agents
Czasopismo naukowe
Tytuł:
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?
Autorzy:
Brosolo G; Department of Medicine, University of Udine, 33100 Udine, Italy.; European Hypertension Excellence Center, Clinica Medica, University of Udine, 33100 Udine, Italy.
Da Porto A; Department of Medicine, University of Udine, 33100 Udine, Italy.; Diabetes and Metabolism Unit, Clinica Medica, University of Udine, 33100 Udine, Italy.
Marcante S; Department of Medicine, University of Udine, 33100 Udine, Italy.
Picci A; Department of Medicine, University of Udine, 33100 Udine, Italy.
Capilupi F; Department of Medicine, University of Udine, 33100 Udine, Italy.
Capilupi P; Department of Medicine, University of Udine, 33100 Udine, Italy.
Bertin N; Department of Medicine, University of Udine, 33100 Udine, Italy.; Thrombosis and Hemostasis Unit, Clinica Medica, University of Udine, 33100 Udine, Italy.
Vivarelli C; Department of Medicine, University of Udine, 33100 Udine, Italy.
Bulfone L; Department of Medicine, University of Udine, 33100 Udine, Italy.; European Hypertension Excellence Center, Clinica Medica, University of Udine, 33100 Udine, Italy.
Vacca A; Department of Medicine, University of Udine, 33100 Udine, Italy.; European Hypertension Excellence Center, Clinica Medica, University of Udine, 33100 Udine, Italy.
Catena C; Department of Medicine, University of Udine, 33100 Udine, Italy.; European Hypertension Excellence Center, Clinica Medica, University of Udine, 33100 Udine, Italy.
Sechi LA; Department of Medicine, University of Udine, 33100 Udine, Italy.; European Hypertension Excellence Center, Clinica Medica, University of Udine, 33100 Udine, Italy.; Diabetes and Metabolism Unit, Clinica Medica, University of Udine, 33100 Udine, Italy.; Thrombosis and Hemostasis Unit, Clinica Medica, University of Udine, 33100 Udine, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 30; Vol. 24 (11). Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Fatty Acids, Omega-3*/therapeutic use
Hypertension*/drug therapy
Humans ; Docosahexaenoic Acids/therapeutic use ; Eicosapentaenoic Acid/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Antihypertensive, antioxidant, and renal protective impact of integrated GJD with captopril in spontaneously hypertensive rats.
Autorzy:
Mohammed SAD; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.; School of Pharmacy, Lebanese International University, 18644, Sana'a, Yemen.
Liu H; Graduate School of Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Baldi S; Research Center of Molecular Diagnostics and Sequencing, Axbio Biotechnology (Shenzhen) Co., Ltd., Shenzhen, 518057, Guangdong, China.
Wang Y; Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Chen P; Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Lu F; Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Liu S; Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 06; Vol. 13 (1), pp. 10944. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*
Rats ; Animals ; Captopril/pharmacology ; Captopril/therapeutic use ; Rats, Inbred SHR ; Antioxidants/pharmacology ; Kidney/pathology ; Blood Pressure
Czasopismo naukowe
Tytuł:
Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients' Real Problems: Chronic Dry Cough and Angioedema.
Autorzy:
Manoharan S; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, Shah Alam 40170, Malaysia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jun 02; Vol. 28 (11). Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biological Products*/pharmacology
Biological Products*/therapeutic use
Hypertension*/drug therapy
Hypertension*/chemically induced
Angioedema*/drug therapy
Angioedema*/chemically induced
Humans ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/chemistry ; Angiotensin Receptor Antagonists/therapeutic use ; Cough/drug therapy ; Molecular Docking Simulation
Czasopismo naukowe
Tytuł:
Prevalence, awareness, treatment and control of high blood pressure in a cohort in Northern Andean Peru.
Autorzy:
Sanchez-Samaniego G; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.
Hartinger SM; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.; School of Public Health and Administration, Universidad Peruana Cayetano Heredia, UPCH, Lima, Peru.
Mäusezahl D; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.
Hattendorf J; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.
Fink G; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.
Probst-Hensch N; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Faculty of Science, University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
Global health action [Glob Health Action] 2023 Dec 31; Vol. 16 (1), pp. 2285100. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/epidemiology
Adult ; Humans ; Female ; Peru/epidemiology ; Prevalence ; Cross-Sectional Studies ; Blood Pressure
Czasopismo naukowe
Tytuł:
Gut microbiota and hypertension: association, mechanisms and treatment.
Autorzy:
Yang Z; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Wang Q; The Inner Mongolia Institute of Chinese and Mongolian medicine, Hohhot, China.
Liu Y; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Wang L; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Ge Z; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Li Z; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Feng S; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Wu C; School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2195135.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Gastrointestinal Microbiome*/physiology
Hypertension*/etiology
Hypertension*/therapy
Probiotics*/therapeutic use
Humans ; Fecal Microbiota Transplantation/adverse effects ; Risk Factors
Czasopismo naukowe
Tytuł:
Predictors of non-adherence to antihypertensive medications: A cross-sectional study from a regional hospital in Afghanistan.
Autorzy:
Stanikzai MH; Public Health Research Program, School of Public Health, Walailak University, Thai Buri, Thailand.; Excellent Center for Dengue and Community Public Health (EC for DACH), Walailak University, Thai Buri, Thailand.; Faculty of Medicine, Department of Public Health, Kandahar University, Kandahar, Afghanistan.
Wafa MH; Faculty of Medicine, Neuropsychiatric and Behavioral science Department, Kandahar University, Kandahar, Afghanistan.
Tawfiq E; The Kirby Institute, UNSW Sydney, Sydney, Australia.
Jafari M; McMaster University, Hamilton, Ontario, Canada.
Le CN; Public Health Research Program, School of Public Health, Walailak University, Thai Buri, Thailand.; Excellent Center for Dengue and Community Public Health (EC for DACH), Walailak University, Thai Buri, Thailand.
Wasiq AW; Faculty of Medicine, Department of Internal Medicine, Kandahar University, Kandahar, Afghanistan.
Rahimi BA; Department of Pediatrics, Faculty of Medicine, Kandahar University, Kandahar, Afghanistan.
Baray AH; Faculty of Medicine, Department of Public Health, Kandahar University, Kandahar, Afghanistan.
Ageru TA; Public Health Research Program, School of Public Health, Walailak University, Thai Buri, Thailand.; Excellent Center for Dengue and Community Public Health (EC for DACH), Walailak University, Thai Buri, Thailand.
Suwanbamrung C; Public Health Research Program, School of Public Health, Walailak University, Thai Buri, Thailand.; Excellent Center for Dengue and Community Public Health (EC for DACH), Walailak University, Thai Buri, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 27; Vol. 18 (12), pp. e0295246. Date of Electronic Publication: 2023 Dec 27 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; Adolescent ; Adult ; Cross-Sectional Studies ; Afghanistan/epidemiology ; Hospitals ; Medication Adherence
Czasopismo naukowe
Tytuł:
Improving the availability of antihypertensive drugs in the India Hypertension Control Initiative, India, 2019-2020.
Autorzy:
Kunwar A; Dept of Noncommunicable Diseases, WHO Country Office for India, New Delhi, India.
Kaur P; Division of Noncommunicable Diseases, ICMR-National Institute of Epidemiology, Chennai, India.
Durgad K; Dept of Noncommunicable Diseases, WHO Country Office for India, New Delhi, India.
Parasuraman G; Division of Noncommunicable Diseases, ICMR-National Institute of Epidemiology, Chennai, India.
Sharma M; Indian Council of Medical Research (ICMR), New Delhi, India.
Gupta S; Directorate General of Health Services, Ministry and Health, and Family Welfare, New Delhi, India.
Bhargava B; Indian Council of Medical Research (ICMR), New Delhi, India.
Pokaż więcej
Corporate Authors:
"India Hypertension Control Initiative (IHCI) collaboration
Źródło:
PloS one [PLoS One] 2023 Dec 14; Vol. 18 (12), pp. e0295338. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; India/epidemiology ; Amlodipine
Czasopismo naukowe
Tytuł:
Latest Knowledge on the Role of Vitamin D in Hypertension.
Autorzy:
Jensen NS; Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus, Denmark.
Wehland M; Department of Microgravity and Translational Regenerative Medicine, University Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University, 39106 Magdeburg, Germany.
Wise PM; The Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.
Grimm D; Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus, Denmark.; Department of Microgravity and Translational Regenerative Medicine, University Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University, 39106 Magdeburg, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 28; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*/therapy
Vitamin D*/pharmacology
Vitamin D*/therapeutic use
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Animals ; Humans ; Mice ; Adrenergic beta-Antagonists/pharmacology ; Adrenergic beta-Antagonists/therapeutic use ; Angiotensin Receptor Antagonists/pharmacology ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Renin-Angiotensin System ; Receptors, Calcitriol/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies